David Ragoonanan is a pharmacist who is specialized in Critical Care in Sarasota, Florida. Patients can reach him at 1700 S Tamiami Trl, Sarasota or contact him on 941-917-2895. Active license number of David Ragoonanan is PS59338 for Critical Care in Florida. David Ragoonanan is a licensed pharmacist who has demonstrated specialized knowledge and skill in the delivery of patient care services by pharmacists, as integral members of interprofessional teams, working to ensure the safe and effective use of medications in critically ill patients.
Complete Profile:
David Ragoonanan speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
David Ragoonanan
Specialization:
Critical Care
Gender:
Male
Location:
1700 S Tamiami Trl, Sarasota, Florida, 34239-3509
Phone:
941-917-2895
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of David Ragoonanan are as mentioned below.
NPI Number:
1356226013
NPI Enumeration Date:
11 Aug, 2025
NPI Last Update On:
11 Aug, 2025
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for David Ragoonanan are as mentioned below.
Specialization
License Number
State
Status
Critical Care
PS59338
Florida
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1700 S Tamiami Trl, Sarasota, Florida
Zip:
34239-3509
Phone Number:
--
Fax Number:
--
Patients can reach David Ragoonanan at 1700 S Tamiami Trl, Sarasota, Florida or can call on phone at 941-917-2895.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 October, 2025.